Skip to content

Study on the Difference of Intestinal Microecology for Lung and Spleen Qi Deficiency Children with Recurrent Respiratory Tract Infections

Study on the Difference of Intestinal Microecology for Lung and Spleen Qi Deficiency Children with Recurrent Respiratory Tract Infections

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000039123
Enrollment
Unknown
Registered
2020-10-17
Start date
2020-10-20
Completion date
Unknown
Last updated
2021-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent Respiratory Tract Infections

Interventions

Sponsors

GuangDong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 6 Years

Inclusion criteria

Inclusion criteria: 1. Children meet the definition of healthy children or the diagnostic criteria for recurrent respiratory tract infections; 2. Children aged 3-6 years; 3. Chileren with regular diet and the frequency of defecation meet the normal range in daily life; 4. Children who can cooperate with the treatment and sampling; 5. During the study period, parents are willing to maintain a stable daily diet and living environment. If necessary, strictly limitation of the use of prebiotics, probiotics, synbiotics and antibiotics shall be complied. Participants promise that they will not move house, will not travel to other provinces or transfer to another school; ; 6. Guardian signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with other diseases that may lead to intestinal flora disorder, such as gastrointestinal diseases such as diarrhea, inflammatory bowel disease, hepatobiliary diseases such as cholestatic liver disease, etc.; 2. Patients with persistent asthma, eczema and other allergic diseases; 3. Patients requiring hospitalization or undergoing tumor treatment; 4. Patients with phlebitis, open wound, fracture and muscle tissue injury.

Design outcomes

Primary

MeasureTime frame
Metagenome of fecal microbiota;

Secondary

MeasureTime frame
Lactobacillus,bifidobacteria and other beneficial bacteria;

Countries

China

Contacts

Public ContactWu Darong

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine Guangdong Provincial Hospital of Chinese Medicine

darongwu@gzucm.edu.cn+86 13808869436

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026